Currently, the therapies to treat knee pain from osteoarthritis are limited. Most current treatments are only designed to relieve pain and reduce the disability caused by bone and cartilage degeneration. Drug therapies target the symptoms but not the cause of the disease. Rochester Clinical Research is currently enrolling individuals between the ages of 40 – 80 for a research study of a new study drug aimed at reversing the degenerative changes in your cartilage and bone. The study drug would be administered through a single injection in the knee with the most pain.
View Trial Details